about
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialProgress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.Conjugate vaccines.Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever.An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.Key issues in the clinical development and implementation of TB vaccines in South Africa.Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.Novel licensure pathways for expeditious introduction of new tuberculosis vaccines: a discussion of the adaptive licensure concept.Mouse hemithoracic irradiation and its interaction with cytotoxic drugs.Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a haemophilus influenzae type B conjugate vaccine in United Kingdom infants.Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1×, 2×, or 4×) in healthy subjects aged 70 years or olderA clinical trial examining the effect of increased total CRM197 carrier protein dose on the antibody response to Haemophilus influenzae type b CRM197 conjugate vaccinePhase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adultsSafety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of ageInhaled thiol and phosphorothiol radioprotectors fail to protect the mouse lungThe effect of low dose-rate and cyclophosphamide on the radiation tolerance of the mouse lungAlloxan therapy for nesidioblastosisEmesis due to cancer chemotherapy: Results of a prospective, randomised, double-blind trial of varying doses of metoclopramide in the management of cis-platinum-induced vomitingTopical silver sulphadiazine: Side effects and urinary excretion
P50
Q29620144-134D4E59-5BC3-4727-9488-A7F95B981945Q30366891-391ACC09-3F84-435D-81B2-6C051C70FDA1Q34774773-BA53DA1F-72AB-40D3-A065-67E750016E6CQ35623292-2205B13B-BDBA-419F-8F01-1CB19AA95CD0Q36105906-99D790CE-6598-46D1-AA49-6558CD5F8650Q36715923-A43F343D-DDD3-43DD-A205-A2630ED4149CQ36949893-787C1DE4-BEA5-4F2A-8000-C3AFC2D050E5Q37696581-4CF9FC8C-B700-406D-A615-B38735FC5B72Q38069725-8612F16E-A46B-4C72-9916-774A7A00A710Q38415782-FD60E9A1-33E5-436F-8A49-C3FB7285497EQ38721154-F14EF298-4A15-44D8-AE5F-E990D90BBE85Q40011528-E504C24C-A877-4B30-81F5-88726D02BBC8Q42235955-C9005C25-5B54-471A-A98D-C00F943E61A0Q43584373-8F448830-59F9-41F0-896D-6EDE03860040Q54035898-12E4E4CA-3B38-48C9-B9CF-721E5BBDD2E3Q57276293-9F9FE61A-2EED-44D5-95E0-EE2C4C48C6ADQ57276295-0CECC250-37B5-4095-A1F1-0F2E6764D477Q57276297-37E385AC-CCFA-41E3-94B8-6C9F32E24FD2Q57276305-47BAB6C2-0968-4B36-B7C2-CFBBAC22CDC3Q57276311-70D1A9C9-26BB-42A4-B013-CCF724AC6CF7Q57276315-1DF137D2-68E7-441E-A17E-5B1A80B6FA79Q57276321-723FE145-84AC-422C-8D7E-53F8251B5839Q57276324-BC05DF24-3518-4C29-A586-17B120C3D66CQ57276325-AB823D5F-D05B-492D-97D2-8EBC8BE15CB5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephen Lockhart
@ast
Stephen Lockhart
@en
Stephen Lockhart
@es
Stephen Lockhart
@nl
Stephen Lockhart
@sl
type
label
Stephen Lockhart
@ast
Stephen Lockhart
@en
Stephen Lockhart
@es
Stephen Lockhart
@nl
Stephen Lockhart
@sl
prefLabel
Stephen Lockhart
@ast
Stephen Lockhart
@en
Stephen Lockhart
@es
Stephen Lockhart
@nl
Stephen Lockhart
@sl
P106
P21
P31
P496
0000-0002-0805-2193